The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Abdugaffarova N.A.

Republican scientific center of oncology

Umarova S.G.

Republican scientific center of oncology

Secondary prevention of cervical cancer in modern conditions

Authors:

Abdugaffarova N.A., Umarova S.G.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2020;9(4): 42‑48

Read: 2438 times


To cite this article:

Abdugaffarova NA, Umarova SG. Secondary prevention of cervical cancer in modern conditions. P.A. Herzen Journal of Oncology. 2020;9(4):42‑48. (In Russ.)
https://doi.org/10.17116/onkolog2020904142

Recommended articles:
Impact of various reha­bilitation programs on anxiety and depression after surgery of early-stage cervical cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):40-44
Surgical treatment of intramedullary spinal cord tumors: a systematic review. Burdenko's Journal of Neurosurgery. 2025;(1):103-108
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Modern methods of treatment of latent form of HPV infe­ction: clinical obse­rvation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):425-429
The exoskeleton of the hand in modern habi­litation and reha­bilitation (analytical review). Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(3):53-61
DNA base editors are a promising tool to gene therapy of human viral infe­ctions. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(3):4-8

References:

  1. Prilepskaya VN, Mgeryan AN, Nazarova NM, Kostava MN. HPV-associated cervical diseases in women with autoimmune diseases: vaccination. Obstetrics and Gynecology/Akusherstvo i ginekologiya. 2016;(5):44-48. (In Russ.). https://doi.org/10.18565/aig.2016.5.44-48
  2. Canadian Consensus Guidelines on Human Papillomavirus. J Obstet Gynaecol Can. 2007;29(8 suppl 3):1-60. 
  3. Richart RM. Cervical intraepithelial neoplasia. Pathol. Ann. 1973;8:301-328. 
  4. Beyerstein LE. Nobel Prize awarded to virologist who linked HPV to cervical cancer. 2011. Accessed 11 September 2019. https://rewire.news/article/2008/10/21/nobel-prize-awarded-virologist-who-linked-hpv-cervical-cancer/
  5. WHO. World Health Organization. Comprehensive cervical cancer control. A guide to essential practice. Geneva: WHO; 2006.
  6. Khashukoeva AZ, Geinits AV, Rekhviashvili SA. Fotodinamicheskaya terapiya fonovykh i predrakovykh zabolevanii sheiki matki. Metodicheskoe posobie dlya vrachei. M. 2005. (In Russ.).
  7. Protasova AE, Dzyubii TI, Raskin GA. Displaziya sheiki matki — etiopatogenez, diagnostika, optimal’naya taktika lecheniya. Uchebnoe posobie. SPb. 2014. (In Russ.).
  8. WHO. World Health Organization. Geneva: WHO; 2018. https://doi.org/10.3322/caac.21492
  9. Dubrovina SO. Pervichnaya i vtorichnaya profilaktika raka sheiki matki (po materialam rekomendatsii Amerikanskogo obshchestva klinicheskoi onkologii (Mart 2017). Consilium medicum. 2017;(6):66-71. (In Russ.).
  10. Wright T, Zhang G, Behrens CM. Screening with prejudice: how knowledge of patients HPV status impact the performance of cervical cytology in the ATHENA trial. In: Abstracts 15th World Congress for Cervical Pathology and Colposcopy (IFCPC 2014). 26.05-30.05 2014 London. 2014.
  11. Ul’yanova IO, Makarenko TA, Nikiforova DE, Domracheva MYa. Kol’poskopiya kak ekspertnyi metod diagnostiki patologii sheiki matki. Sibirskoe meditsinskoe obozrenie. 2016;(6):99-106. (In Russ.).
  12. Cox JT. The clinician’s view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors. Arch Pathol Lab Med. 2003;127(8):950-958. 
  13. WHO. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: WHO; 2013.
  14. WHO. WHO guidelines: use of cryotherapy for cervical intraepithelial neoplasia. Geneva: WHO; 2011.
  15. Prilepskaya VN, Novikova EP, Sulamanidze LA, Mzareula GM. Papillomavirusnaya infekciya. Vozmozhnosti lecheniya i profilaktiki s primeneniem inozin pranobeksa. Akusherstvo i ginekologiya. 2013;10:99-103. (In Russ.).
  16. Belocerkovceva LD, Abazeva OV, Orudzhova EA, Davydov AI. Effektivnost kombinirovannogo lecheniya patologii sheiki matki, assotsiirovannoi. s HPV-infection. Voprosy ginekologii, akusherstva i perinatologii. 2015;4:21-25. (In Russ.).
  17. Kononova IN, Oboskalova TA, Voroshilina ES, Percova YuV. Znachenie immunomoduliruyushchej terapii (primenenie vaginal’nyh suppozitoriev) v kompleksnom lechenii VPCH-associirovannyh neoplazij. Ginekologiya. 2014;5:40-43. (In Russ.).
  18. WHO handbook for guideline development. Geneva: World Health Organization; 2010. Accessed 6 August 2013. https://www.who.int/hiv/topics/mtct/grc_handbook_mar2010_1.pdf
  19. WHO handbook for guideline development. Geneva: WHO; 2012. Accessed 6 August 2013. https://apps.who.int/iris/bitstream/10665/75146/1/9789241 548441_eng.pdf
  20. Zaronchenceva LK, Logutova LS, Dzhidzhihiya LK. Taktika vedeniya pacientok s cervikalnymi intraepitelial’nymi neoplaziyami i neobhodimost’ primeneniya protivovirusnoj terapii. RMZh. 2016;5:305-311. (In Russ.).
  21. Novikov AI, Kononov AV, Vaganova IG. Sexually transmitted infections and exocervix. M.: Meditsina; 2002. (In Russ.).
  22. Bestaeva NV, Nazarova NM, Prilepskaya VN. Papillomavirusnaya infekciya, obuslovlennaya virusom papillomy cheloveka 52- go i 58- go tipov, i ee rol’ v razvitii cervikal’nyh intraepitelial’nyh neoplazij. Akusherstvo i ginekologiya. 2013;7:45-50. (In Russ.).
  23. Provencher DM, Murphy J. The role of HPV testing. Canadian consensus guidelines on human papillomavirus. J Obstet Gynaecol Can. 2007;8:1-60. 
  24. Giannella L, Fodero C, Boselli F, Mfuta K, Rubino T, Prandi S. Age-related changes in the diagnostic assessment of women with severe cervical lesions. Climacteric. 2015;20:1-18. 
  25. Akopova ES, Rogovskaya SI, Bebneva TN, Badalova LA. VPCH-associirovannaya patologiya genitalij: aktual’nye voprosy diagnostiki i lecheniya. Rossijskij vestnik akushera-ginekologa. 2011;4:94-98. (In Russ.).
  26. Ibragimova MK, Cyganov MM, Karabut IV, Churuksaeva ON i dr. Integrativnaya i episomal’naya formy genotipa 16 virusa papillomy cheloveka pri cervikal’nyh intraepitelial’nyh neoplaziyah i rake shejki matki. Voprosy virusologii. 2016;6:270-274. (In Russ.).
  27. Khayridinova JB. Features of cervical disease in women of reproductive age in the region of high fertility: Dis. ... kand. med. nauk. Dushanbe. 2009. (In Russ.).
  28. Kedrova AG, Levakov SA, Carenko MD. Otdalennye rezul’taty lecheniya dobrokachestvennyh izmenenij epiteliya shejki matki, associirovannyh s virusom papillomy cheloveka. Opuholi zhenskoj reproduktivnoj sistemy. 2016;2:77-83. (In Russ.).
  29. Shipulina OYu, Popova AA, Kravchenko AV, Deulina MO, Dmitryukova MYu, Romanyuk TN. Rasprostranenie vysoko-onkogennyh genotipov virusa papillomy cheloveka u VICH-pozitivnyh i VICH-negativnyh zhenshchin. Infekcionnye bolezni. 2016;4:26-30. (In Russ.).
  30. Cubie HA, Seagar AL, Beattie GJ, et al. A longitudinal study of HPV detection and cervical pathology in HIV infected women. Sex Transm Infect. 2000;76:257-251. 
  31. De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, Tenet V, Njoroge JW, Sakr SR, Meijer CM, Snijders PJ, Rana FS, Franceschi S. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012;107(9):1624-1630. https://doi.org/10.1038/bjc.2012.441
  32. Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol. 2008;111(6):1380-1387. https://doi.org/10.1097/AOG.0b013e3181743327
  33. Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U. Screening of cervical neoplasia in HIV-infected women in India. AIDS. 2013;27(4):607-615.  https://doi.org/10.1097/QAD.0b013e32835b1041
  34. Koffi B, Serdouma E, Mbolissa-Nguérékoudou W, Ngadjou-Kouchou-Fondjo M, Pengoussou-Gbatoumba V, Sépou A, Grésenguet G. Cervical dysplasia in women with human immunodeficiency virus (HIV) in areas of high prevalence of infection. Gynecol Obstet Fertil. 2010;38(10):576-580. 
  35. Schneider A. Primary, secondary and tertiary prevention of cervical cancer. 2nd ed. Institute for Cytology and Displasia; 2015.
  36. Shabalova IP. Cytological atlas. Criteria for the diagnosis of cervical diseases. M. 2001. (In Russ.).
  37. Roik EE, Baranov AN, Usynin MV. Papillomavirusnaya infekciya skrining i vakcinaciya. Zhurnal akusherstva i zhenskih boleznej. 2014;63(6):38-43. (In Russ.).
  38. Minkina GN. Zachem nuzhna planovaya vakcinaciya devochek-podrostkov protiv VPCH? Voprosy sovremennoj pediatrii. 2011;1:106-110. (In Russ.).
  39. Shahtahtinskaya FCh, Namazova-Baranova LS, Tatochenko VK. et al. Virus papillomy cheloveka. Profilaktika VPCH-associirovannyh zabolevanij. Pediatricheskaya farmakologiya. 2015;1:74-78. (In Russ.).
  40. Krasnopolskij VI, Logutova LS, Zarochenceva NV, Belaya YuM. et al. Rezul’taty vakcinoprofilaktiki VPCH-associirovannyh zabolevanij i raka shejki matki v Moskovskoj oblasti. Rossijskij vestnik akushera-ginekologa. 2015;3:9-14. (In Russ.).
  41. Kuz’mickaya EV, Mihel’son AF, Lebedenko EYu, Sazonova VA. Osobennosti samatotipov inficirovannyh virusom papillomy cheloveka zhenshchin s polozhitel’nym rezul’tatom immunocitohimicheskogo opredeleniya ekspressii onkomarkera pl6ink4a. Profilakticheskaya i klinicheskaya meditsina. 2014;1:121-126. (In Russ.).
  42. Mal’ceva LI, Ahmetzyanova AV, Farrahova LN, Nigmatullina NA. Cervikal’naya intraepitelial’naya neoplaziya: vozmozhnosti diagnostiki i lecheniya. Prakticheskaya meditsina. 2012;9:52-59. (In Russ.).
  43. Zhelezin OV, Smetanina SV, Dolgova SV. Rol’ skrininga v ocenke zabolevaemosti rakom shejki matki. Medicinskij al’manah. 2016;2:34-37. (In Russ.).
  44. Aktanko AP, Boytsova TYu, Klimkovich NM. The results of cytological screening of smears of fingerprints of the cervix as a marker of intraepithelial pathological changes. Healthcare of the Far East. 2018;2:51-54. (In Russ.).
  45. Zhukembaeva AM, Abralinova SS, Bajmagambetova GA. et al. Onkologicheskaya nastorozhennost’ pri vedenii pacientok s patologiej shejki matki. Vestnik Kazahskogo Nacional’nogo meditsinskogo universiteta. 2016;1:23-27. (In Russ.).
  46. World Health Organization. Human papillomavirus and cervical cancer. WHO; 2019. Accessed 11 September 2019. (In Russ.). https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
  47. Umarova SG. Analiz zabolevaemosti zhenshchin zlokachestvennymi opuholyami organov reproduktivnoj sistemy po regionam respubliki. Doklady Akademii nauk Respubliki Tadzhikistan. 2011;54(11):946-951. (In Russ.).
  48. Zdorov’ye naseleniya i deyatel’nost’ uchrezhdeniy zdravookhraneniya v 2018: Gosudarstvennoye uchrezhdeniye respublikanskiy tsentr statistiki i meditsinskoy informatsii Ministerstva zdravookhraneniya i sotsial’noy zashchity Respubliki Tadzhikistan. Dushanbe; 2019. (In Russ.).
  49. Wiley Online Library. CA: A Cancer Journal for Clinicians. — Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality for 36 cancers in 185 countries. https://doi.org/10.3322/caac.21492
  50. Ghebraysus TA. A world free of cervical cancer. General Director of the UN General Assembly, 09.24.2018. New York, USA. Accessed 11 September 2019. (In Russ.). https://www.who.int/dg/speeches/2018/UNGA-cervical-cancer/ru/

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.